KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE) Cash from Restructuring (2017 - 2025)

Historic Cash from Restructuring for Global Medical REIT (GMRE) over the last 9 years, with Q3 2025 value amounting to $16000.0.

  • Global Medical REIT's Cash from Restructuring rose 4545.45% to $16000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $224000.0, marking a year-over-year increase of 9478.26%. This contributed to the annual value of $242000.0 for FY2024, which is 3672.32% up from last year.
  • Global Medical REIT's Cash from Restructuring amounted to $16000.0 in Q3 2025, which was up 4545.45% from $149000.0 recorded in Q4 2024.
  • In the past 5 years, Global Medical REIT's Cash from Restructuring ranged from a high of $154000.0 in Q3 2022 and a low of $11000.0 during Q3 2024
  • Its 5-year average for Cash from Restructuring is $63235.3, with a median of $45000.0 in 2021.
  • In the last 5 years, Global Medical REIT's Cash from Restructuring tumbled by 9019.61% in 2023 and then surged by 57727.27% in 2024.
  • Over the past 5 years, Global Medical REIT's Cash from Restructuring (Quarter) stood at $45000.0 in 2021, then skyrocketed by 184.44% to $128000.0 in 2022, then plummeted by 82.81% to $22000.0 in 2023, then soared by 577.27% to $149000.0 in 2024, then crashed by 89.26% to $16000.0 in 2025.
  • Its last three reported values are $16000.0 in Q3 2025, $149000.0 for Q4 2024, and $11000.0 during Q3 2024.